A pharmacokinetic standard for babies and adults.
暂无分享,去创建一个
[1] H. Halliday,et al. Intravenous indometacin in preterm infants with symptomatic patent ductus arteriosus. A population pharmacokinetic study. , 2004, British journal of clinical pharmacology.
[2] D. Tibboel,et al. Tramadol disposition in the very young: an attempt to assess in vivo cytochrome P-450 2D6 activity. , 2005, British journal of anaesthesia.
[3] S. Gesase,et al. Population Pharmacokinetic and Pharmacodynamic Properties of Intramuscular Quinine in Tanzanian Children with Severe Falciparum Malaria , 2012, Antimicrobial Agents and Chemotherapy.
[4] P. Babyn,et al. Changes in gastric emptying in early postnatal life. , 1997, The Journal of pediatrics.
[5] D. Tibboel,et al. Diclofenac pharmacokinetic meta‐analysis and dose recommendations for surgical pain in children aged 1–12 years , 2011, Paediatric anaesthesia.
[6] D. Kaufman,et al. Population Pharmacokinetics of Fluconazole in Young Infants , 2008, Antimicrobial Agents and Chemotherapy.
[7] D. Tibboel,et al. A Bodyweight-Dependent Allometric Exponent for Scaling Clearance Across the Human Life-Span , 2012, Pharmaceutical Research.
[8] L. Wiesner,et al. Exploring the pharmacokinetics of oral ketamine in children undergoing burns procedures , 2011, Paediatric anaesthesia.
[9] S. Tibby,et al. Extended-interval gentamicin: Population pharmacokinetics in pediatric critical illness , 2010, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[10] N. Merchant,et al. Pharmacokinetics of melatonin in preterm infants. , 2013, British journal of clinical pharmacology.
[11] A W Kelman,et al. Estimation of gentamicin clearance and volume of distribution in neonates and young children. , 1984, British journal of clinical pharmacology.
[12] J. Bartlett,et al. Population Pharmacokinetics of Lamivudine in Adult Human Immunodeficiency Virus-Infected Patients Enrolled in Two Phase III Clinical Trials , 1999, Antimicrobial Agents and Chemotherapy.
[13] N. Holford,et al. Prediction of morphine dose in humans , 2012, Paediatric anaesthesia.
[14] G. Koren,et al. Ontogeny of drug elimination by the human kidney , 2006, Pediatric Nephrology.
[15] M O Karlsson,et al. Developmental pharmacokinetics of ciclosporin--a population pharmacokinetic study in paediatric renal transplant candidates. , 2007, British journal of clinical pharmacology.
[16] P. Sánchez,et al. Single-Dose Pharmacokinetics of Famciclovir in Infants and Population Pharmacokinetic Analysis in Infants and Children , 2010, Antimicrobial Agents and Chemotherapy.
[17] J. McElnay,et al. Population pharmacokinetics of single-dose intravenous paracetamol in children. , 2012, British journal of anaesthesia.
[18] J. Lerman,et al. Dexmedetomidine pharmacokinetics in pediatric intensive care – a pooled analysis , 2009, Paediatric anaesthesia.
[19] James H. Brown,et al. A General Model for the Origin of Allometric Scaling Laws in Biology , 1997, Science.
[20] J. Clements,et al. Pharmacokinetics and analgesic effect of ketamine in man. , 1981, British journal of anaesthesia.
[21] J. Fourtillan,et al. Bioavailability of melatonin in humans after day-time administration of D(7) melatonin. , 2000, Biopharmaceutics & drug disposition.
[22] S. Bell,et al. Population Pharmacokinetics of Itraconazole and its Active Metabolite Hydroxy-Itraconazole in Paediatric Cystic Fibrosis and Bone Marrow Transplant Patients , 2006, Clinical pharmacokinetics.
[23] M. Wiesen,et al. Remifentanil Degradation in Umbilical Cord Blood of Preterm Infants , 2011, Anesthesiology.
[24] G. Hempel,et al. Population Pharmacokinetics of Amphotericin B Lipid Complex in Neonates , 2005, Antimicrobial Agents and Chemotherapy.
[25] C. Coté,et al. Uptake pharmacokinetics of the Fentanyl Oralet® in children scheduled for central venous access removal: implications for the timing of initiating painful procedures , 2002, Paediatric anaesthesia.
[26] B. Anderson,et al. The Pharmacokinetics of Ketorolac After Single Postoperative Intranasal Administration in Adolescent Patients , 2012, Anesthesia and analgesia.
[27] M. Kuss,et al. A Pharmacokinetic Study of Intramuscular (IM) Parecoxib Sodium in Normal Subjects , 2001, Journal of clinical pharmacology.
[28] S. Urien,et al. Developmental Pharmacokinetics of Lamivudine in 580 Pediatric Patients Ranging from Neonates to Adolescents , 2011, Antimicrobial Agents and Chemotherapy.
[29] Nicholas H. G. Holford,et al. A Size Standard for Pharmacokinetics , 1996, Clinical pharmacokinetics.
[30] Geoffrey B. West,et al. The predominance of quarter-power scaling in biology , 2004 .
[31] J. McElnay,et al. Prophylactic ranitidine treatment in critically ill children--a population pharmacokinetic study. , 2013, British journal of clinical pharmacology.
[32] F. Suchy,et al. Physiologic cholestasis: Elevation of the primary serum bile acid concentrations in normal infants , 1981 .
[33] S. Schug,et al. Recent Advances in the Pharmacokinetics of Local Anaesthetics , 1999, Clinical pharmacokinetics.
[34] G. Warman,et al. Clonidine disposition in children; a population analysis , 2007, Paediatric anaesthesia.
[35] Hong-Guang Xie,et al. Clonidine Clearance Matures Rapidly During the Early Postnatal Period: A Population Pharmacokinetic Analysis in Newborns With Neonatal Abstinence Syndrome , 2011, Journal of clinical pharmacology.
[36] P. Krasilnikoff,et al. Parietal cell secretory function in early childhood. , 1967, Scandinavian journal of gastroenterology.
[37] C. Kirkpatrick,et al. Target concentration intervention is needed for tobramycin dosing in paediatric patients with cystic fibrosis--a population pharmacokinetic study. , 2008, British journal of clinical pharmacology.
[38] C. Kirkpatrick,et al. The Relationship between Drug Clearance and Body Size , 2012, Clinical Pharmacokinetics.
[39] N. Holford,et al. Quantitative justification for target concentration intervention--parameter variability and predictive performance using population pharmacokinetic models for aminoglycosides. , 2004, British journal of clinical pharmacology.
[40] Jennifer M Butler,et al. Free Drug Metabolic Clearance in Elderly People , 2008, Clinical pharmacokinetics.
[41] Stephanie Läer,et al. Population pharmacokinetics and dose simulation of carvedilol in paediatric patients with congestive heart failure. , 2008, British journal of clinical pharmacology.
[42] J. L. Rosenberger,et al. Transmucosal Administration of Midazolam for Premedication of Pediatric Patients: Comparison of the Nasal and Sublingual Routes , 1993, Anesthesiology.
[43] C. Owen,et al. BILE ACIDS IN INFANTS AND CHILDREN. , 1964, The Journal of laboratory and clinical medicine.
[44] Cockcroft Dw,et al. Prediction of Creatinine Clearance from Serum Creatinine , 1976 .
[45] B. Walther,et al. Pharmacokinetic predictions in children by using the physiologically based pharmacokinetic modelling , 2008, Fundamental & clinical pharmacology.
[46] J. R. Sneyd,et al. Remifentanil-midazolam sedation for paediatric patients receiving mechanical ventilation after cardiac surgery. , 2007, British journal of anaesthesia.
[47] P. Siba,et al. Pharmacokinetic Properties of Conventional and Double-Dose Sulfadoxine-Pyrimethamine Given as Intermittent Preventive Treatment in Infancy , 2011, Antimicrobial Agents and Chemotherapy.
[48] N. Holford,et al. Tips and traps analyzing pediatric PK data , 2011, Paediatric anaesthesia.
[49] R. V. van Lingen,et al. Acetaminophen Developmental Pharmacokinetics in Premature Neonates and Infants: A Pooled Population Analysis , 2002, Anesthesiology.
[50] F. Torti,et al. Development of the Human Gastrointestinal Tract: A Review , 1976 .
[51] M. Gupta,et al. Gastric retention in neonates. , 1978, Pediatrics.
[52] M. Struys,et al. Influence of obesity on propofol pharmacokinetics: derivation of a pharmacokinetic model. , 2010, British journal of anaesthesia.
[53] U. Dubach,et al. Plasma concentrations in pyrimethamine and sulfadoxine and evaluation of pharmacokinetic data by computerized curve fitting. , 1982, Bulletin of the World Health Organization.
[54] K. Allegaert,et al. Covariates of amikacin clearance in neonates: the impact of postnatal age on predictability. , 2008, Drug Metabolism Letters.
[55] K. Maitland,et al. Dosing regimens of oral ciprofloxacin for children with severe malnutrition: a population pharmacokinetic study with Monte Carlo simulation , 2011, The Journal of antimicrobial chemotherapy.
[56] U. Klotz,et al. The effects of age and liver disease on the disposition and elimination of diazepam in adult man. , 1975, The Journal of clinical investigation.
[57] Amin Rostami-Hodjegan,et al. Changes in liver volume from birth to adulthood: A meta‐analysis , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[58] V. Biran,et al. External Evaluation of Population Pharmacokinetic Models of Vancomycin in Neonates: The transferability of published models to different clinical settings. , 2013, British journal of clinical pharmacology.
[59] J. Gobburu,et al. Population Pharmacokinetic–Based Dosing of Intravenous Busulfan in Pediatric Patients , 2007, Journal of clinical pharmacology.
[60] V. Fellman,et al. Thiopentone elimination in newborn infants: exploring Michaelis–Menten kinetics , 2011, Acta anaesthesiologica Scandinavica.
[61] N H Holford,et al. Target concentration intervention: beyond Y2K. , 2001, British journal of clinical pharmacology.
[62] N. Holford,et al. Mechanism-based concepts of size and maturity in pharmacokinetics. , 2008, Annual review of pharmacology and toxicology.
[63] F. Lokiec,et al. Pharmacokinetics of Oral Acyclovir in Neonates and in Infants: a Population Analysis , 2001, Antimicrobial Agents and Chemotherapy.
[64] D. Mould,et al. Population pharmacokinetic and adverse event analysis of topotecan in patients with solid tumors , 2002, Clinical pharmacology and therapeutics.
[65] N. Huang,et al. Comparison of serum levels following the administration of oral and parenteral preparations of penicillin to infants and children of various age groups. , 1953, The Journal of pediatrics.
[66] N. Holford,et al. Size, Myths and the Clinical Pharmacokinetics of Analgesia in Paediatric Patients , 1997, Clinical pharmacokinetics.
[67] B. Anderson,et al. A maturation model for midazolam clearance , 2011, Paediatric anaesthesia.
[68] S. Higuchi,et al. Population pharmacokinetics of tamsulosin hydrochloride in paediatric patients with neuropathic and non-neuropathic bladder. , 2010, British journal of clinical pharmacology.
[69] S. Salman,et al. Development of a Population Pharmacokinetic Model for Parecoxib and Its Active Metabolite Valdecoxib after Parenteral Parecoxib Administration in Children , 2012, Anesthesiology.
[70] H. Scheinin,et al. Bioavailability of dexmedetomidine after extravascular doses in healthy subjects. , 2003, British journal of clinical pharmacology.
[71] N. Holford,et al. Mechanistic basis of using body size and maturation to predict clearance in humans. , 2009, Drug metabolism and pharmacokinetics.
[72] G. Glass,et al. Correlative study of hydrochloric acid, pepsin, and intrinsic factor secretion in newborns and infants , 1969, The American Journal of Digestive Diseases.
[73] S. Urien,et al. Population Pharmacokinetics of Tenofovir in HIV-1–Infected Pediatric Patients , 2011, Journal of acquired immune deficiency syndromes.
[74] L. Aarons,et al. Population pharmacokinetics and optimal design of paediatric studies for famciclovir. , 2009, British journal of clinical pharmacology.
[75] N. Holford,et al. Predicting weight using postmenstrual age – neonates to adults , 2011, Paediatric anaesthesia.
[76] S. Khoo,et al. Lopinavir/ritonavir population pharmacokinetics in neonates and infants. , 2011, British journal of clinical pharmacology.
[77] W. Engle. Age Terminology During the Perinatal Period , 2004, Pediatrics.
[78] I. Murat,et al. Maturational pharmacokinetics of single intravenous bolus of propofol , 2007, Paediatric anaesthesia.
[79] M. Wiese,et al. Predicted metabolic drug clearance with increasing adult age. , 2013, British journal of clinical pharmacology.
[80] P. Moore. Children are not small adults , 1998, The Lancet.
[81] M. Coulthard,et al. Human renal function maturation: a quantitative description using weight and postmenstrual age , 2009, Pediatric Nephrology.
[82] R. Gristwood,et al. Levobupivacaine: a new safer long acting local anaesthetic agent. , 1999, Expert opinion on investigational drugs.
[83] N. Holford,et al. Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance. , 2007, British journal of clinical pharmacology.
[84] D. Tibboel,et al. From Pediatric Covariate Model to Semiphysiological Function for Maturation: Part II—Sensitivity to Physiological and Physicochemical Properties , 2012, CPT: pharmacometrics & systems pharmacology.
[85] R. Jelliffe,et al. Distribution and elimination of tobramycin administered in single or multiple daily doses in adult patients with cystic fibrosis. , 2002, The Journal of antimicrobial chemotherapy.
[86] B. Friis‐Hansen. Body water compartments in children: changes during growth and related changes in body composition. , 1961, Pediatrics.
[87] G. Schwartz. Does kL/PCr estimate GFR, or does GFR determine k? , 1992, Pediatric Nephrology.
[88] A. Bensman,et al. Population Pharmacokinetics and Pharmacogenetics of Tacrolimus in De Novo Pediatric Kidney Transplant Recipients , 2009, Clinical pharmacology and therapeutics.
[89] R. Shellhaas,et al. Population Pharmacokinetics of Phenobarbital in Infants With Neonatal Encephalopathy Treated With Therapeutic Hypothermia* , 2013, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[90] J Schüttler,et al. Population Pharmacokinetics of Propofol: A Multicenter Study , 2000, Anesthesiology.
[91] J. Chen,et al. Development of gastric slow waves in preterm infants measured by electrogastrography. , 1998, American journal of physiology. Gastrointestinal and liver physiology.
[92] G. Chazot,et al. Pharmacokinetics of melatonin in man after intravenous infusion and bolus injection , 2004, European Journal of Clinical Pharmacology.
[93] M. Gastonguay,et al. Population Pharmacokinetic Modeling of Pantoprazole in Pediatric Patients From Birth to 16 Years , 2011, Journal of clinical pharmacology.
[94] B. Anderson,et al. Age and size are the major covariates for prediction of levobupivacaine clearance in children , 2006, Paediatric anaesthesia.
[95] J. Barrett,et al. Population pharmacokinetics of intravenous ondansetron in oncology and surgical patients aged 1−48 months , 2009, European Journal of Clinical Pharmacology.